iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
50 hedge funds and large institutions have $330M invested in iKang Healthcare Group, Inc. in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 11 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
74% more call options, than puts
Call options by funds: $805K | Put options by funds: $462K
35% more funds holding
Funds holding: 37 → 50 (+13)
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
4% more capital invested
Capital invested by funds: $315M → $330M (+$14.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$32.3M |
| 2 |
VAM
Visium Asset Management
New York
|
+$14M |
| 3 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
+$11.7M |
| 4 |
JCP
Jabre Capital Partners
Geneva,
Switzerland
|
+$7.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$6.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$14.2M |
| 2 |
SC
Sculptor Capital
New York
|
-$12.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.19M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$1.82M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.71M |
KANG Hedge Fund Activity: Q4 2014 in Review
50 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q4 2014, worth a combined $330M — up 4.5% from $315M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new KANG positions and 11 closed out — a net gain of 14 holders — while 10 added to existing stakes and 9 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $32.3M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $14.2M sold.
- 50 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q4 2014, up from 37 in Q3 2014.
- Funds reported $330M of iKang Healthcare Group, Inc. stock for Q4 2014, up 4.5% quarter-over-quarter.
- 25 funds opened new iKang Healthcare Group, Inc. positions in Q4 2014 and 11 closed out, a net change of +14 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q4 2014 was JP Morgan Chase, an estimated $32.3M added.
- The largest iKang Healthcare Group, Inc. seller in Q4 2014 was Driehaus Capital Management, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2014.